LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Zevra Therapeutics Inc

Open

8.35 0.24

Overview

Share price change

24h

Current

Min

8.22

Max

8.48

Key metrics

By Trading Economics

Income

-75M

-544K

Sales

182K

26M

P/E

Sector Avg

18.234

121.746

Profit margin

-2.087

Employees

59

EBITDA

73M

1.5M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+191.72% upside

Dividends

By Dow Jones

Next Earnings

10 mar 2026

Market Stats

By TradingEconomics

Market Cap

-91M

482M

Previous open

8.11

Previous close

8.35

Zevra Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 lut 2025, 15:29 UTC

Acquisitions, Mergers, Takeovers

Zevra Therapeutics to Sell Priority-Review Voucher for $150 Million

Peer Comparison

Price change

Zevra Therapeutics Inc Forecast

Price Target

By TipRanks

191.72% upside

12 Months Forecast

Average 25 USD  191.72%

High 26 USD

Low 24 USD

Based on 3 Wall Street analysts offering 12 month price targets forZevra Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat